bioequivalence trial

bioequivalence trial

A mandatory trial, conducted under an abbreviated new drug (ANDA) trial filed with the FDA, based on 20 to 40 healthy subjects, to ensure that the 2 products being evaluated do not differ in safety and efficacy and compare the bioavailability when administered at the same dosages.
Examples, summary measures
A BT records pharmacokinestic measures, but does not assess, clinical improvement or lack thereof. In a BT, summary measures of the plasma concentration vs time profile are used to compare 2 formulations of a drug product; equivalence of area under the curve (AUC), maximum plasma concentration (Cmax) and time to maximum concentration (Tmax) summary measures, does not guarantee equivalence of the entire profile.